Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

Popular Articles

Orion Announced Plans to Shut Down Carbon Black Plants

Orion Announced Plans to Shut Down Carbon Black Plants

Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.

Ratcliffe: Chemical Industry in Europe at a Tipping Point

Ratcliffe: Chemical Industry in Europe at a Tipping Point

Ineos CEO Ineos calls on European politicians to save the chemical industry.

Jens Birgersson Becomes New Brenntag CEO

Jens Birgersson Becomes New Brenntag CEO

Jens Birgersson becomes new Brenntag CEO

Media Kit

Photo

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.